株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の輸液装置市場の予測:輸液ポンプ、インスリンポンプ、経腸栄養ポンプ

Global Infusion Devices Market Forecast to 2027: Infusion Pumps, Insulin Pumps, Enteral Feeding Pumps, Other Infusion Pumps

発行 Visiongain Ltd 商品コード 235219
出版日 ページ情報 英文 231 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=155.30円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
世界の輸液装置市場の予測:輸液ポンプ、インスリンポンプ、経腸栄養ポンプ Global Infusion Devices Market Forecast to 2027: Infusion Pumps, Insulin Pumps, Enteral Feeding Pumps, Other Infusion Pumps
出版日: 2017年12月15日 ページ情報: 英文 231 Pages
概要

当レポートでは、世界の輸液装置市場について調査分析し、二次市場の収益予測、促進要因・抑制要因、主要製品、SWOT分析、ファイブフォース分析など、体系的な情報を提供しています。

第1章 レポート概要

第2章 輸液ポンプのイントロダクション

  • 輸液の種類
  • ポンプの種類
  • 輸液ポンプの歴史
  • 輸液ポンプが有用となる臨床環境
  • 輸液ポンプの利点と欠点

第3章 輸液ポンプ:世界市場

  • 世界の医療機器市場
  • 輸液ポンプ市場の定義
  • 世界の輸液ポンプ市場
  • 世界の輸液ポンプ市場の予測
  • 輸液ポンプ市場:インスリンポンプが主導
  • 市場シェアの変動
  • 世界の輸液ポンプ市場:促進要因・抑制要因

第4章 主要国市場

  • 世界の輸液ポンプ市場の地域別内訳
  • 輸液ポンプの国別市場の予測
  • 米国
  • EU
  • 日本
  • 中国
  • インド
  • ブラジル
  • 韓国
  • ロシア

第5章 インスリンポンプ二次市場

  • イントロダクション
  • インスリンポンプのインスリン
  • インスリンポンプの利点と欠点
  • ヒトインスリン・類似体
  • インスリン輸液ポンプ二次市場
  • インスリンポンプ二次市場の地域別内訳
  • インスリンポンプ二次市場:売上予測
  • インスリンポンプ二次市場の主要製品
  • インスリンポンプ主要パイプライン製品
  • インスリンポンプ二次市場:促進要因・抑制要因
  • 先進国:採用が増加
  • インスリンポンプの償還が長期的な経済利益を提供
  • 新興市場の参入時は高額な技術が障壁に
  • インスリンポンプの安全上のリスク

第6章 経腸栄養ポンプ二次市場

  • イントロダクション
  • 結腸栄養法
  • 経腸栄養ポンプ二次市場:売上予測
  • 経腸栄養ポンプ二次市場の主要製品
  • 経腸栄養ポンプ二次市場:促進要因・抑制要因

第7章 その他の輸液ポンプ二次市場

  • その他の輸液ポンプ二次市場の定義
  • その他の輸液ポンプ二次市場
  • その他の輸液ポンプ二次市場:売上予測
  • 化学療法用ポンプ
  • PCA (自己調節鎮痛) 用ポンプ

第8章 競合技術の分析

  • ドラッグデリバリー技術
  • ドラッグデリバリー技術の種類
  • 世界のドラッグデリバリー技術市場
  • ドラッグデリバリー技術市場の地域別内訳
  • 世界のドラッグデリバリー技術市場の予測
  • 主要なドラッグデリバリーパイプライン製品

第9章 輸液ポンプ市場の定性分析

  • SWOT分析
  • 強み
  • 弱み
  • 機会
  • 脅威
  • ファイブフォース分析

第10章 結論

付録

目次
Product Code: PHA0268

The global infusion devices market is expected to grow at a CAGR of 6.2% in the first half of the forecast period. In 2016, the insulin pumps submarket held the 31% of the global infusion devices market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 231-page report you will receive 83 tables and 65 figures - all unavailable elsewhere.

The 231-page report provides clear detailed insight into the global infusion devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global Medical Infusion Devices market forecasts to 2027
  • This report also breaks down the revenue forecast for global infusion devices market by these submarkets :
    • Insulin pumps,
    • Enteral feeding pumps
    • Other pumps (a grouped category inclusive of chemotherapy pumps and PCA infusion pumps)

image1

This report analyses and dicusses the drivers and restraints for each submarket.

  • Our work also shows individual revenue forecasts to 2027 for 12 national markets:
    • United States (US)
    • Japan
    • EU leaders - Germany, France, the UK, Italy and Spain (EU5)
    • BRIC nations - Brazil, Russia, India and China.
    • South Korea
    • RoW
  • Our work also shows individual revenue forecasts to 2027 for the Global Drug Delivery Technology market, broken down by these submarkets:
    • Oral drug delivery
    • Inhalation drug delivery
    • Injectable/implantable drug delivery
    • Transdermal drug delivery
    • Ocular drug delivery
    • Nasal drug delivery
  • This report discusses the leading products in the global infusion devices market, from several leading companies, including:
    • ALCOR Scientific
    • Altea Therapeutics
    • Animas Corporation
    • B.Braun
    • Baxter
    • CareFusion
    • Cellnovo
    • Covidien
    • D. Medical Industries
    • Danone Nutricia
    • Debiotech
    • Disetronic (Roche)
    • Fresenius Kabi
    • Hospira
    • Insulet Corporation
    • Johnson & Johnson
    • Medline
    • MedSolve Technologies
    • Medtronic
    • Q Core Medical
    • Roche
    • Smiths Medical
    • SOOIL
    • Tandem Diabetes Care
    • Valeritas
    • Zevex
  • This report provides a SWOT analysis of the major strengths and weaknesses of the market, together with the opportunities available and the key threats faced. Moreover, this report proves Porter's Five Forces Analysis of the global infusion devices market.

Visiongain's study is for everybody needing commercial analyses for the Infusion Pumps market and leading companies. You will find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 World Infusion Pumps Market Segmentation
  • 1.2 Why You Should Read This Report
  • 1.3 How This Report Delivers: Chapter Outline
  • 1.4 Key Questions Answered by This Analytical Report
  • 1.5 Who is This Report For?
  • 1.6 Methodology
  • 1.7 Frequently Asked Questions (FAQ)
  • 1.8 Associated Visiongain Reports
  • 1.9 About Visiongain

2. Introduction to Infusion Pumps

  • 2.1 Types of Infusion
  • 2.2 Types of Pumps
    • 2.2.1 Gravity Controlled Infusion
    • 2.2.2 Positive Displacement Pumps
    • 2.2.3 Drip Rate Pumps
    • 2.2.4 Volumetric Pumps
    • 2.2.5 Syringe Pumps
    • 2.2.6 Multi-Channel Pumps
    • 2.2.7 Ambulatory Pumps
  • 2.3 History of Infusion Pumps
  • 2.4 What Clinical Settings Will Infusion Pumps Be Useful For?
    • 2.4.1 Infusion Pumps for Diabetes
    • 2.4.2 Infusion Pumps for Chemotherapy
    • 2.4.3 Infusion Pumps for Analgesia
    • 2.4.4 Infusion Pumps for Enteral Feeding
    • 2.4.5 Other Uses for Infusion Pumps
  • 2.5 Advantages and Disadvantages of Infusion Pumps

3. Infusion Pumps: World Market, 2016-2027

  • 3.1 World Medical Devices Market, 2016-2027
  • 3.2 Infusion Pump Market Definition
  • 3.3 World Infusion Pumps Market, 2016
  • 3.4 World Infusion Pumps Market Forecast, 2016-2027
    • 3.4.1 The Infusion Pumps Market Forecast, 2016-2021
    • 3.4.2 The Infusion Pumps Market Forecast, 2022-2027
  • 3.5 The Infusion Pumps Market: Insulin Pumps Are Market Leaders
  • 3.6 How Will Segmental Market Shares Change to 2027?
  • 3.7 World Infusion Pumps Market: Drivers and Restraints, 2016-2027
    • 3.7.1 Ageing Population and Rising Incidences of Chronic Diseases
    • 3.7.2 Advancement in Infusion Pump Technologies
    • 3.7.3 A Shift towards Home Care
    • 3.7.4 Safety Risk and Stringent Approval Process

4. Leading National Markets, 2016-2027

  • 4.1 Regional Breakdown of World Infusion Pumps Market, 2016
  • 4.2 Infusion Pumps National Market Forecast, 2016-2027
    • 4.2.1 How Will National Market Shares Change to 2027?
  • 4.3 US Infusion Pumps Market, 2016-2027
    • 4.3.1 US Medical Device Regulations, 2016-2027
    • 4.3.2 US Infusion Pumps Market Forecast, 2016-2027
  • 4.4 EU Infusion Pumps Market 2016
    • 4.4.1 EU Medical Device Approval and Regulations
    • 4.4.2 The EU Approval and Regulation System
    • 4.4.3 Changes in the New EU Medical Device Regulations
    • 4.4.4 Post Marketing Surveillance in the EU
    • 4.4.5 EU Infusion Pumps Market Forecast, 2016-2027
    • 4.4.6 How Will EU Market Shares Change to 2027?
    • 4.4.7 German Infusion Pumps Market Forecast, 2016-2027
    • 4.4.8 French Infusion Pumps Market Forecast, 2016-2027
    • 4.4.9 UK Infusion Pumps Market Forecast, 2016-2027
    • 4.4.10 Italian Infusion Pumps Market Forecast, 2016-2027
    • 4.4.11 Spanish Infusion Pumps Market Forecast, 2016-2027
  • 4.5 Japanese Infusion Pumps Market, 2016
    • 4.5.1 Japan: Improved Approval Process
    • 4.5.2 Japanese Infusion Pumps Market Forecast, 2016-2027
  • 4.6 Chinese Infusion Pumps Market, 2016
    • 4.6.1 Chinese Infusion Pumps Market Forecast, 2016-2027
    • 4.6.2 China's 12th Five-Year-Plan (2010-2015)
    • 4.6.3 New Policies Favouring Domestically-Made Medical Devices
  • 4.7 Indian Infusion Pumps Market 2016
    • 4.7.1 Indian Infusion Pumps Market Forecast, 2016-2027
  • 4.8 Brazilian Infusion Pumps Market, 2016
    • 4.8.1 Brazilian Infusion Pumps Market Forecast, 2016-2027
  • 4.9 South Korean Infusion Pumps Market, 2016
    • 4.9.1 South Korean Infusion Pumps Market Forecast, 2016-2027
  • 4.10 Russian Infusion Pumps Market, 2016
    • 4.10.1 Russian Infusion Pumps Market Forecast, 2016-2027

5. Insulin Pumps Submarket, 2016-2027

  • 5.1 Introduction to Insulin Pumps
  • 5.2 Insulin in Insulin Pumps
    • 5.2.1 Bolus Infusion
    • 5.2.2 Basal Infusion
  • 5.3 Advantages and Disadvantages of Insulin Pumps
  • 5.4 Human Insulin and Analogues
  • 5.5 Insulin Infusion Pumps Submarket, 2016
  • 5.6 Insulin Pumps Submarket Regional Breakdown, 2016
  • 5.7 Insulin Pumps Submarket: Sales Forecast, 2016-2027
  • 5.8 Insulin Pumps Submarket: Sales Forecast, 2016-2021
  • 5.9 Insulin Pumps Submarket: Sales Forecast, 2022-2027
  • 5.10 Leading Products in Insulin Pumps Submarket, 2016
    • 5.10.1 MiniMed (Medtronic)
    • 5.10.2 OmniPod (Insulet Corporation)
    • 5.10.3 OneTouch Ping (Animas Corporation)
    • 5.10.4 Accu-Chek Spirit (Disetronic, subsidiary of Roche)
    • 5.10.5 t:Slim (Tandem Diabetes Care)
    • 5.10.6 Animas Vibe (Animas Acquired by Johnson & Johnson)
    • 5.10.7 DANA Diabecare IISG (SOOIL)
    • 5.10.8 SpringZone (D. Medical Industries)
    • 5.10.9 Cellnovo (Cellnovo)
    • 5.10.10 V-Go (Valeritas)
  • 5.11 Key Insulin Pumps Pipeline Products, 2016
    • 5.11.1 Finesse Personal Insulin Patch (Johnson & Johnson)
    • 5.11.2 SOLO MicroPump (Roche)
    • 5.11.3 Artificial Pancreas (Juvenile Diabetes Research Foundation)
    • 5.11.4 Freehand (MedSolve Technologies)
    • 5.11.5 NanoPump (Debiotech)
    • 5.11.6 PassPort (Altea Therapeutics)
    • 5.11.7 NiliPatch (D. Medical Industries)
  • 5.12 Insulin Pumps Submarket: Drivers and Restraints, 2016-2027
    • 5.12.1 Increased Competition Drives Innovation
    • 5.12.2 Collaborating to Address Unmet Needs
    • 5.12.3 A Strong R&D Pipeline Will Drive the Market
    • 5.12.4 Diabetes Globalisation: A Rapidly Increasing Incidence
  • 5.13 Developed Economies: Increasing Adoption
  • 5.14 Reimbursement of Insulin Pumps Will Give Long-Term Economic Benefits
  • 5.15 More Expensive Technology Presents a Challenge When Entering Emerging Markets
  • 5.16 Security Risks with Insulin Pumps

6. Enteral Feeding Pumps Submarket, 2016-2027

  • 6.1 Introduction to Enteral Feeding Pumps
    • 6.1.1 Clinical Settings That May Require Enteral Feeding
    • 6.1.2 Advantages and Disadvantages of Enteral Feeding
  • 6.2 Delivery of Enteral Feeding
    • 6.2.1 Tube Placements Used in Enteral Feeding
    • 6.2.2 Enteral Feeding at Home
    • 6.2.3 Enteral Feeding Pumps Submarket, 2016
    • 6.2.4 Enteral Feeding Pumps Submarket Regional Breakdown, 2016
  • 6.3 Enteral Feeding Pumps Submarket: Sales Forecast, 2016-2027
    • 6.3.1 Enteral Feeding Pumps Submarket: Sales Forecast, 2016-2021
    • 6.3.2 Enteral Feeding Pumps Submarket: Sales Forecast, 2022-2027
  • 6.4 Leading Products in Enteral Feeding Pump Submarket 2016
    • 6.4.1 Compat DualFlo Enteral Feeding Pump (Acquired by Medline)
    • 6.4.2 Sentinel Enteral Feeding Pump (ALCOR Scientific)
    • 6.4.3 EnteraLite Infinity Enteral Feeding Pump (Zevex /Moog)
    • 6.4.4 APPLIX Vision (Fresenius Kabi)
    • 6.4.5 MiniFlo (Fresenius Kabi)
    • 6.4.6 Nutricia FloCare Infinity Pump (Danone Nutricia)
    • 6.4.7 Sapphire (Q Core Medical)
    • 6.4.8 Kangaroo Joey Enteral Feeding Pump (Covidien)
    • 6.4.9 Other Notable Enteral Feeding Pumps
  • 6.5 Enteral Feeding Pumps Submarket: Drivers and Restraints, 2016-2027
    • 6.5.1 Cost-Effective, Portable and Safer Products Will Drive Growth
    • 6.5.2 Growing World Geriatric Population and Prevalence of Chronic Diseases
    • 6.5.3 Increasing Demand for Homecare Solutions and Portability
    • 6.5.4 Exit of Abbott in the US Enteral Feeding Market in 2015
    • 6.5.5 Introduction of ISO's Standards for Small-Bore Connectors
    • 6.5.6 Replacement of Pumps and Sales of Disposable Feeding Sets Will Sustain Market Revenue
    • 6.5.7 Highly Competitive Market with High Barriers to Entry

7. Other Infusion Pumps Submarket, 2016-2027

  • 7.1 Other Infusion Pumps Submarket Definition
  • 7.2 Other Infusion Pumps Submarket, 2016
  • 7.3 Other Infusion Pumps Submarket: Sales Forecast, 2016-2027
  • 7.4 Chemotherapy Pumps
  • 7.5 Advantages and Disadvantages of Chemotherapy Pumps
  • 7.6 Leading Drugs in the Oncology Therapeutics Market, 2016
  • 7.7 The Chemotherapy Pumps Market, 2016
  • 7.8 Leading Products in Chemotherapy Pumps Market, 2016
    • 7.8.1 Infusor Infusion Pump (Baxter)
    • 7.8.2 CODMAN 3000 (Johnson & Johnson)
    • 7.8.3 Optima MS (Fresenius Kabi)
    • 7.8.4 CADD Legacy-1 (Smiths Medical)
    • 7.8.5 Other Notable Chemotherapy Pumps
  • 7.9 Chemotherapy Pumps Market: Drivers and Restraints, 2016-2027
  • 7.10 Patient Controlled Analgesia (PCA) Pumps
    • 7.10.1 Clinical Settings Where PCA Pumps Are Used
    • 7.10.2 How Does a PCA Pump Work?
    • 7.10.3 Advantages and Disadvantages of PCA Pumps
  • 7.11 Narcotic Drugs
  • 7.12 Leading Products in the PCA Pumps Market 2016
    • 7.12.1 LifeCare PCA 7.0 with Hospira MedNet Software (Hospira)
    • 7.12.2 Alaris PCA (CareFusion)
    • 7.12.3 Baxter PCA II (Baxter)
    • 7.12.4 Curlin PainSmart IOD Pain Management System (B.Braun)
    • 7.12.5 CADD-Solis Infusion Pump (Smiths Medical)
    • 7.12.6 Other Notable PCA Pumps
  • 7.13 PCA Pumps Market: Drivers and Restraints, 2016-2027

8. Competing Technology Analysis, 2016-2027

  • 8.1 Drug Delivery Technologies
  • 8.2 Types of Technologies for Drug Delivery
    • 8.2.1 Sustained/Controlled Release Systems
    • 8.2.2 Injection
    • 8.2.3 Needle Free Injections
    • 8.2.4 Pulmonary, Buccal and Nasal Delivery
    • 8.2.5 Pills and Capsules
  • 8.3 World Drug Delivery Technologies Market, 2016
  • 8.4 Drug Delivery Technologies Market Regional Breakdown, 2016
  • 8.5 World Drug Delivery Technologies Market Forecast, 2016-2027
  • 8.6 Key Drug Delivery Pipeline Products, 2016

9. Qualitative Analysis of the Infusion Pumps Market, 2016-2027

  • 9.1 SWOT Analysis of World Infusion Pumps Market, 2016-2027
  • 9.2 Strengths
    • 9.2.1 Highly Accurate Dosing at Regular Intervals
    • 9.2.2 Improved Quality of Life and Less Hospital Visits
    • 9.2.3 Used in a Wide Range of Clinical Settings
  • 9.3 Weaknesses
    • 9.3.1 Safety Concerns Will Call for Stricter Regulation
    • 9.3.2 Discomfort May Discourage Potential Users
    • 9.3.3 Expensive Technologies May Restrain the Market
  • 9.4 Opportunities
    • 9.4.1 Emerging Economies Are Growing
    • 9.4.2 Patient Demographics
    • 9.4.3 High Demand for Technological Advancements
    • 9.4.4 Drugs Coming Off-Patent Will Help to Drive the Market
  • 9.5 Threats
    • 9.5.1 Poor Economic Conditions in Key Regions of the Market
    • 9.5.2 Cost Effectiveness May Be Difficult to Prove
    • 9.5.3 Regulatory Bodies Can Make Entry to Market Difficult
    • 9.5.4 Technological Advances in Drug Delivery May Surpass Those in Infusion
  • 9.6 Porter's Five Forces Analysis of the Infusion Pumps Market
    • 9.6.1 Competitive Market Leaders [High]
    • 9.6.2 Threat of New Entrants [Medium]
    • 9.6.3 Power of Suppliers [Medium]
    • 9.6.4 Bargaining Power of Buyers [High]
    • 9.6.5 Threat of Substitutes [Medium]

10. Conclusion

  • 10.1 Infusion Pumps: A Growing Industry
  • 10.2 Current Look at the World Infusion Pumps Market, 2016
  • 10.3 The Global Infusion Pumps Market: Driven or Restrained?

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Report Evaluation Form

List of Figures

  • Figure 1.1 Top Five National Infusion Pumps Market by Revenue, 2016 & 2027
  • Figure 1.2 World Infusion Pumps Market Segmentation Overview, 2016
  • Figure 2.1 Positive Displacement Pump Mechanism
  • Figure 3.1 World Medical Devices Market Forecast: Revenue ($bn) 2016-2027
  • Figure 3.2 World Infusion Pumps Market Forecast: Revenue ($bn), 2016-2027
  • Figure 3.3 World Infusion Pumps Market Forecast: Revenues ($bn) by Segment, 2016-2027
  • Figure 3.4 World Infusion Pumps Market: Market Shares (%) by Segment, 2016
  • Figure 3.5 World Infusion Pumps Market: Market Shares (%) by Segment, 2021
  • Figure 3.6 World Infusion Pumps Market: Market Shares (%) by Segment, 2027
  • Figure 3.7 World Infusion Pumps Market: Drivers and Restraints, 2016-2027
  • Figure 4.1 World Infusion Pumps Market: Revenue ($bn) by Region, 2016
  • Figure 4.2 World Infusion Pumps Market: Market Shares (%) by Region, 2016
  • Figure 4.3 World Infusion Pumps Market Forecast: Comparison between Revenue ($bn) by Region, 2016, 2021, and 2027
  • Figure 4.4 World Infusion Pumps Market Forecast: CAGR (%) by Region in 2016-2021, 2022-2027, and 2016-2027
  • Figure 4.5 World Infusion Pumps Market: Market Shares (%) by Region, 2021
  • Figure 4.6 World Infusion Pumps Market: Market Shares (%) by Region, 2027
  • Figure 4.7 US 65+ Population Forecast: Size (m), 2016-2027
  • Figure 4.8 US Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
  • Figure 4.9 EU5 Infusion Pumps Market: Leading Countries by Revenue ($bn), 2016
  • Figure 4.10 EU5 Infusion Pumps Market: Leading Countries by Market Share (%), 2016
  • Figure 4.11 EU5 Infusion Pumps Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 4.12 EU5 Infusion Pumps Market Forecast: Revenues ($bn) by Leading Countries, 2016-2027
  • Figure 4.13 EU5 Infusion Pumps Market Forecast: CAGR (%) by Leading Countries in 2016-2021, 2022-2027 and 2016-2027
  • Figure 4.14 EU5 Infusion Pumps Market: EU Market Shares (%) by Leading Countries, 2021
  • Figure 4.15 EU5 Infusion Pumps Market: EU Market Shares (%) by Leading Countries, 2027
  • Figure 4.16 Germany Infusion Pumps Market Forecast: Revenues ($bn) 2016-2027
  • Figure 4.17 French Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
  • Figure 4.18 UK Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
  • Figure 4.19 Italian Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
  • Figure 4.20 Spanish Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
  • Figure 4.21 Japanese Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
  • Figure 4.22 Chinese Infusion Pumps Market Forecast: Revenues ($bn) 2016-2027
  • Figure 4.23 China's Historical Healthcare Expenditure ($bn), 2001-2010
  • Figure 4.24 Chinese Population: Aged 65 or Over (million) in 1950, 2010 and 2050
  • Figure 4.25 Indian Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
  • Figure 4.26 Brazilian Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
  • Figure 4.27 South Korean Infusion Pumps Market Forecast: Revenues ($bn) 2016-2027
  • Figure 4.28 Russian Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
  • Figure 5.1 Insulin Analogues Submarket: Revenue ($bn) by Leading Products, 2016
  • Figure 5.2 Insulin Analogues Submarket: Leading Products by Market Shares (%), 2016
  • Figure 5.3 Insulin Pumps Submarket: Revenues ($bn) by Region, 2016
  • Figure 5.4 World Insulin Pumps Market: Market Shares (%) by Region, 2016
  • Figure 5.5 Insulin Pumps Submarket Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 5.6 Insulin Pumps Submarket: Drivers and Restraints, 2016-2027
  • Figure 5.7 Diabetes Prevalence (%) in Leading National Markets, 2016
  • Figure 6.1 Conditions That Require The Use Of Enteral Feeding Pumps, 2016
  • Figure 6.2 Enteral Feeding Pumps Submarket: Revenues ($bn) by Region, 2016
  • Figure 6.3 World Enteral Feeding Pumps Market: Market Shares (%) by Region, 2016
  • Figure 6.4 Enteral Feeding Pumps Submarket: Drivers and Restraints, 2016-2027
  • Figure 7.1 Other Infusion Pumps Submarket Forecast: Revenue ($bn), 2016-2027
  • Figure 7.2 Top 10 Oncology Pharmaceuticals: Revenues ($bn), 2016
  • Figure 7.3 Top 10 Oncology Pharmaceuticals: Market Shares (%), 2016
  • Figure 7.4 Chemotherapy Pumps World Market: Drivers and Restraints, 2016-2027
  • Figure 7.5 Routes of PCA Administration
  • Figure 7.6 PCA Pumps World Market: Drivers and Restraints, 2016-2027
  • Figure 8.1 World Drug Delivery Technologies Market: Revenues ($bn) by Application, 2016
  • Figure 8.2 World Drug Delivery Technologies Market: Market Shares (%) by Application, 2016
  • Figure 8.3 World Drug Delivery Technologies Market: Revenues ($bn) by Country, 2016
  • Figure 8.4 World Drug Delivery Technologies Market: Market Shares (%) by Country, 2016
  • Figure 8.5 Global Drug Delivery Market Forecast: Revenue ($bn) , 2016-2027
  • Figure 9.1 Insulin Delivery Technologies: Average Annual Costs of Usage 2016 ($)
  • Figure 9.2 World Population Aged 65+ Forecast: Population (millions) and AGR (%), 2016-2027
  • Figure 9.3 Porter's Five Forces Analysis of the Infusion Pumps Market, 2016-2027
  • Figure 11.1 Top Five National Infusion Pumps Market by Revenue ($bn), 2016 & 2027
  • Figure 11.2 Main Drivers and Restraints In The Global Infusion Pumps Market, 2016-2027

List of Tables

  • Table 1.1 Infusion Pumps: Leading National Markets Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 2.1 Four Types of Infusion
  • Table 2.2 Advantages and Disadvantages of syringe pumps
  • Table 2.3 Advantages and Disadvantages of Insulin Pumps
  • Table 2.4 Advantages and Disadvantages of Infusion Pumps
  • Table 3.1 World Medical Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 3.1.1 World Medical Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 3.2 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 3.2.1 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 3.3 Market Shares (%) of Infusion Pumps by Market Segment 2016-2021
  • Table 3.3.1 Market Shares (%) of Infusion Pumps by Market Segment 2022-2027
  • Table 3.4 Percentage of the Population Over 65 Years of Age, 2016-2027
  • Table 4.1 Global Infusion Pumps Market: Revenue ($bn) and Market Shares (%) by Region, 2016
  • Table 4.2 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Region, 2016-2027
  • Table 4.2.1 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Region, 2016-2027
  • Table 4.3 World Infusion Pumps Market Forecast: CAGR (%) by Region in 2016-2021, 2022-2027 and 2016-2027
  • Table 4.4 Market Shares (%) of Infusion Pumps Market by Region, in 2016, 2021, and 2027
  • Table 4.4.1Classification of Medical Devices in the United States
  • Table 4.5 US Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.5.1 US Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.6 EU5 Infusion Pumps Market: Revenues ($bn) and EU Market Shares (%) by Leading Countries, 2016-2021
  • Table 4.6.1 EU5 Infusion Pumps Market: Revenues ($bn) and EU Market Shares (%) by Leading Countries, 2022-2027
  • Table 4.7 EU5 Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), Market Share (%) and CAGR (%), 2016-2027
  • Table 4.8 EU5 Infusion Pumps Market Forecast: CAGR (%) by Leading Countries in 2016-2021, 2022-2027 and 2016-2027
  • Table 4.9 EU5 Market Shares (%) of the European Infusion Pumps Market by Leading Countries 2016, 2021, and 2027
  • Table 4.10 Germany Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.10.1 Germany Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.11 French Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.11.1 French Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.12 UK Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.12.1 UK Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.13 Italian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.13.1 Italian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.14 Spanish Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.14.1 Spanish Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.15 Japanese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.15.1 Japanese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.16 Chinese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.16.1 Chinese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.17 Indian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.17.1 Indian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.18 Brazilian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.18.1 Brazilian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.19 South Korean Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.19.1 South Korean Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.20 Russian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.20.1 Russian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 5.1 Control of Insulin Delivery (Infusion Types and Methods)
  • Table 5.2 Advantages and Disadvantages of Insulin Pumps
  • Table 5.3 Insulin Analogues Submarket: Leading Products by Revenue ($bn) and Market Shares (%), 2016
  • Table 5.4 Insulin Pumps Submarket: Revenue ($bn) and Market Shares (%) by Region, 2016
  • Table 5.5 Insulin Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 5.5.1 Insulin Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 5.6 Leading Products in the Insulin Pumps Submarket, 2016
  • Table 5.7 Key Pipeline Products for Insulin Pumps Submarket, 2016
  • Table 5.8 Diabetes Prevalence (m) in Leading National Markets, 2016
  • Table 6.1 Advantages and Disadvantages of Enteral Feeding, 2016
  • Table 6.2 Types of Tubes Used in Enteral Feeding, 2016
  • Table 6.3 Enteral Feeding Pumps Submarket: Revenues ($bn) and Market Shares (%) by Region, 2016
  • Table 6.4 Enteral Feeding Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 6.4.1 Enteral Feeding Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 6.5 Leading Products in the Enteral Feeding Pumps Submarket, 2016
  • Table 6.6 Other Products in the Enteral Feeding Pumps Submarket, 2016
  • Table 7.1 Other Infusion Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 7.1.1 Other Infusion Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 7.2 Advantages and Disadvantages of Chemotherapy Pumps
  • Table 7.3 Oncology Pharmaceuticals: Revenue ($bn) and Market Shares (%), 2016
  • Table 7.4 Top 10 Oncology Pharmaceuticals: Key Facts
  • Table 7.5 Leading Products in the Chemotherapy Pump Market, 2016
  • Table 7.6 Advantages and Disadvantages of PCA Pumps
  • Table 7.7 Leading Products in the PCA Pumps Market, 2016
  • Table 7.8 Other Noticeable PCA Pumps
  • Table 8.1 World Drug Delivery Technologies Market: Revenue ($bn) and Market Shares (%) by Application, 2016
  • Table 8.2 World Drug Delivery Technologies Market: Revenue ($bn) and Market Shares (%) by Country, 2016
  • Table 8.3 World Drug Delivery Technologies Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Application, 2016-2021
  • Table 8.3.1 World Drug Delivery Technologies Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Application, 2022-2027
  • Table 8.4 Key Pipeline Products for Oral Delivery, 2016
  • Table 8.5 Key Pipeline Products for Transdermal, Transmucosal, and Implantable Delivery, 2016
  • Table 8.6 Key Pipeline Products for Inhaled and Injectable Delivery, 2016
  • Table 9.1 SWOT Analysis of World Infusion Pumps Market 2016-2027
  • Table 9.2 Average Initial Costs Associated With Insulin Pump Use 2016 ($)
  • Table 9.3 Insulin Delivery Technologies: Average Annual Costs of Usage 2016 ($)
  • Table 9.4 Infusion Pumps and Related Products Recall in the US, 2007-2016

Companies Listed

  • Abbott Nutrition
  • Akas Medical
  • Alcor Scientific
  • Alkermes
  • Allied Medical
  • Altea Therapeutics
  • Amsino International
  • Animas Corporation
  • Aradigm
  • Asante
  • B. Braun
  • Baxter
  • Bayer Healthcare
  • Becton & Dickson & Co
  • Bio-Med
  • BMS
  • Boston Scientific Corporation
  • Calibra Medical
  • Cardinal Health
  • CareFusion
  • Celgene
  • Cellnovo
  • Celsus Laboratories
  • CeQur
  • CME Medical
  • Codman and Shurtleff
  • Conmed Corporation
  • Cook Medical
  • Covidien
  • D. Medical Industries
  • Danone Nutricia
  • Debiotech
  • DePuy
  • Disetronic Medical Systems
  • DreaMed Diabetes
  • Eli Lilly
  • Emco
  • Emisphere
  • Fresenius Kabi
  • GE Medical
  • Generex Biotechnology Corporation
  • Glycologic
  • Hanraj Nayyar Medical India
  • Hospira
  • IBM
  • I-Flow
  • Insulet Corporation
  • Intercell
  • Johnson and Johnson
  • Kimberly Clark Corporation
  • Medingo
  • Medsolve Technologies
  • Medtronic
  • Micrel Medical Devices
  • Mindray
  • Moog
  • NeoDevices
  • NeoMed
  • Nestle Healthcare
  • NiliMEDIX
  • Novartis
  • Noven Pharmaceuticals
  • NovoNordisk
  • Pacira Pharmaceuticals
  • Philips Medical
  • pSivida Corporation
  • Q Core Medical
  • Roche
  • Sanofi
  • Schiller
  • Smith Medical
  • SOOIL
  • Symbios Medical Products
  • Takeda
  • Tandem Diabetics Care
  • Tandem Diagnostics
  • Terumo Medical Corporation
  • Trivitron
  • Valeritas
  • Vectura
  • Vishal Surgical
  • WalkMed Inc
  • Zevex

List of Organizations Mentioned in the Report

  • Agência Nacional de Vigilância Sanitária (ANVISA)
  • American Medical Devices and Diagnostic Association (AMDD)
  • Center for Devices and Radiological Health (CDRH)
  • Centres for Medicare and Medicaid Service (CMS)
  • China Food and Drug Administration (CFDA)
  • China's National Health and Planning Commission (NHPC)
  • Chinese Ministry of Science and Technology
  • Government Accountability Office (GAO)
  • Japanese Ministry of Health, Labour and Welfare (MHLW)
  • Juvenile Diabetes Research Foundation
  • Medical Devices Information & Technology Assistance Centre (MDITAC)
  • Medicines and Healthcare products Regulatory Agency (MHRA)
  • National Competent Authorities (NCAs)
  • National Diabetes Education Program (NDEP)
  • National Institute for Health and Clinical Excellence (NICE)
  • National Medical Devices Authority (NMDA)
  • NHS England
  • Ningbo First Hospital
  • Roszdravnadzor
  • Sahlgrenska Academy
  • Servicio Sanitario Nazionale (SSN)
  • South Korean Ministry for Food and Drug Safety (MFDS)
  • South Korean Ministry of Health and Welfare (MOHW)
  • South Korean Ministry of Science, ICT and Future Planning (MSIP)
  • South Korean Ministry of Trade, Industry and Energy (MOTIE)
  • Único de Saúde (SUS)
  • United Nations Population Division
  • United States Food and Drug Administration (FDA)
  • US Department of Health and Human Services
  • World Bank
  • World Health Organization (WHO)
Back to Top